Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News STERIS plc STE

Consumer Cyclical Healthcare Medical Devices
STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms... see more

Recent & Breaking News (NYSE:STE)

STERIS Declares $0.43 per share Dividend

GlobeNewswire October 28, 2021

STERIS to Host a Conference Call for Fiscal 2022 Second Quarter Financial Results on November 3, 2021

GlobeNewswire October 20, 2021

STERIS Announces Financial Results for Fiscal 2022 First Quarter

GlobeNewswire August 9, 2021

STERIS to Host a Conference Call for Fiscal 2022 First Quarter Financial Results on August 10, 2021

GlobeNewswire July 27, 2021

STERIS Completes the Acquisition of Cantel Medical

GlobeNewswire June 2, 2021

STERIS Announces Financial Results for Fiscal 2021 Fourth Quarter and Full Year

GlobeNewswire May 18, 2021

STERIS Announces Changes to Board of Directors

GlobeNewswire May 11, 2021

STERIS to Host a Conference Call for Fiscal 2021 Fourth Quarter and Full Year Financial Results on May 19, 2021

GlobeNewswire April 27, 2021

STERIS Announces Preliminary Financial Results for Fiscal 2021

GlobeNewswire April 27, 2021

Cantel Medical Reports Strong Financial Results for its Second Quarter Fiscal Year 2021

PR Newswire March 9, 2021

CANTEL MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cantel Medical Corp - CMD

PR Newswire February 9, 2021

STERIS Announces Leadership Succession Plan

GlobeNewswire February 3, 2021

STERIS Announces Financial Results for Fiscal 2021 Third Quarter

GlobeNewswire February 2, 2021

STERIS to Host a Conference Call for Fiscal 2021 Third Quarter Financial Results on February 3, 2021

GlobeNewswire January 19, 2021

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Cantel Medical Corp. Buyout

GlobeNewswire January 13, 2021

SHAREHOLDER ALERT: WeissLaw LLP Investigates Cantel Medical Corp.

PR Newswire January 12, 2021

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cantel Medical Corporation

PR Newswire January 12, 2021

CANTEL ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of CMD and Encourages Investors to Contact the Firm

GlobeNewswire January 12, 2021

STERIS Announces Definitive Agreement to Acquire Cantel Medical

GlobeNewswire January 12, 2021

STERIS To Participate in Upcoming Investor Conferences

GlobeNewswire January 7, 2021